A detailed history of Park Square Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Park Square Financial Group, LLC holds 637 shares of ABT stock, worth $78,745. This represents 0.06% of its overall portfolio holdings.

Number of Shares
637
Previous 430 48.14%
Holding current value
$78,745
Previous $57 Million 51.89%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$123.95 - $138.08 $25,657 - $28,582
207 Added 48.14%
637 $86.6 Million
Q1 2025

Apr 30, 2025

SELL
$111.1 - $140.22 $34,107 - $43,047
-307 Reduced 41.66%
430 $57 Million
Q4 2024

Feb 28, 2025

BUY
$111.93 - $119.39 $82,492 - $87,990
737 New
737 $83.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Park Square Financial Group, LLC Portfolio

Follow Park Square Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Square Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Square Financial Group, LLC with notifications on news.